MLKL and neoplasm: Our study discovered that several antitumor drugs, such as 17-AAG, AMG900, and BOS-172722, were highly effective in patients with high expression of cross-necroptosis genes, particularly MLKL, which may overcome resistance to classical chemotherapy and enhance the anti-tumor effect.